These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2382263)

  • 21. Differential modulation of two interferon-alpha binding proteins on a human lymphoblastoid cell line.
    Faltynek CR; Princler GL; Schwabe M
    Cytokine; 1991 Nov; 3(6):627-35. PubMed ID: 1838703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major proteins induced and down-regulated by interferons in human cultured cells: identification of a unique set of proteins induced by interferon-alpha in epithelial, fibroblast, and lymphoid cells.
    Celis JE; Justesen J; Madsen PS; Lovmand J; Pedersen Ratz G; Celis A
    Leukemia; 1987 Dec; 1(12):800-13. PubMed ID: 3121942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ; Johns TG; Callister KA; Dinatale A; Linnane AW
    Biochem Int; 1990 Dec; 22(6):1095-102. PubMed ID: 2151021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-beta enhances the synthesis of a 20,000-dalton membrane protein: a correlation with the cessation of cell growth.
    Knight E; Fahey D; Blomstrom DC
    J Interferon Res; 1985; 5(2):305-13. PubMed ID: 4009002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane proteins stimulated by interferon-alpha in growth-inhibited, but not in resistant, Daudi cells.
    Quek A; Goding J; Hoogenraad N
    Immunol Cell Biol; 1988; 66 ( Pt 5-6)():353-9. PubMed ID: 3224991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for multiple binding sites for several components of human lymphoblastoid interferon-alpha.
    Hu R; Gan Y; Liu J; Miller D; Zoon KC
    J Biol Chem; 1993 Jun; 268(17):12591-5. PubMed ID: 8509399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-tumor activities of interferon (IFN)-alpha in chronic myelogenous leukaemia (CML)-derived cell lines depends on the IFN-alpha subtypes.
    Yanai Y; Sanou O; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
    Cancer Lett; 2002 Nov; 185(2):173-9. PubMed ID: 12169391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of interferon-consensus 1, interferon-alpha 2a, and interferon-beta 1b on HLA expression and lymphoproliferation: a preclinical model for treatment of multiple sclerosis.
    Dhib-Jalbut S; Jiang H; Xia Q; Blatt L; Johnson KP; Hilt D
    J Interferon Cytokine Res; 1996 Mar; 16(3):195-200. PubMed ID: 8697141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of rIFN alpha, beta, and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cells in vitro.
    Ruszczak Z; Detmar M; Imcke E; Orfanos CE
    J Invest Dermatol; 1990 Dec; 95(6):693-9. PubMed ID: 1979080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of natural beta-interferon and recombinant alpha-2B-interferon on proliferation, glucocorticoid receptor content, and antigen expression in cultured HL-60 cells.
    Sica G; Lama G; Tartaglione R; Pierelli L; Frati L; della Cuna GR; Marchetti P
    Cancer; 1990 Feb; 65(4):920-5. PubMed ID: 2297662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
    Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
    J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
    Yoshida R; Murray HW; Nathan CF
    J Exp Med; 1988 Mar; 167(3):1171-85. PubMed ID: 2965208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
    Sancéau J; Hiscott J; Delattre O; Wietzerbin J
    Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of interferon-alpha on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M-BCR breakpoint.
    Dowding C; Guo AP; Maisin D; Gordon MY; Goldman JM
    Br J Haematol; 1991 Feb; 77(2):165-71. PubMed ID: 2004017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
    Schaber JD; Fang H; Xu J; Grimley PM; Rui H
    Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.
    Rönnblom LE; Janson ET; Perers A; Oberg KE; Alm GV
    Clin Exp Immunol; 1992 Sep; 89(3):330-5. PubMed ID: 1516252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
    Losinno C; Wines BD; Johns TG; Mackay IR
    Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha.
    Geng Y; Choubey D
    J Biol Regul Homeost Agents; 2000; 14(4):263-8. PubMed ID: 11215814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studies.
    Falcone A; Danesi R; Zaccaro L; Pieracci D; Pfanner E; Cianci C; Andreuccetti M; Malvaldi G; Del Tacca M; Conte PF
    Eur J Cancer; 1994; 30A(4):516-20. PubMed ID: 8018411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.